Spero Therapeutics, Inc.
SPRO
$1.87
$0.010.54%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -53.60M | -69.76M | -68.57M | 3.51M | 17.46M |
Total Depreciation and Amortization | 0.00 | 2.00K | 2.00K | 40.00K | 148.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 7.01M | 8.39M | 8.84M | 9.31M | 14.35M |
Change in Net Operating Assets | 14.26M | 27.99M | 36.28M | -30.40M | -46.34M |
Cash from Operations | -32.33M | -33.38M | -23.44M | -17.54M | -14.38M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | 1.00K | 221.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -- | 1.00K | 221.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -32.33M | -33.38M | -23.44M | -17.54M | -14.16M |